Arkolith/Insider Trading/KRRO/Form 4

Agarwal Vineet

Chief Financial OfficerKorro Bio, Inc. (KRRO) · full profile →Form 4 · filed Oct 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$800K
Net Open-Market Flow
-$800K
Transactions
15
13 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 17, 2024Sell(S)56$76.00$4K8K
Oct 17, 2024Sell(S)457$78.59$36K7K
Oct 17, 2024Sell(S)2K$79.79$145K5K
Oct 17, 2024Sell(S)5K$80.50$399K342
Oct 17, 2024Sell(S)317$81.48$26K25
Oct 17, 2024Sell(S)25$82.89$2K0
Oct 17, 2024Sell(S)260$77.55$20K8K
Oct 17, 2024Sell(S)164$73.71$12K8K
Oct 17, 2024Sell(S)2K$71.51$145K8K
Oct 17, 2024Option exercise(M)953$14.98$14K10K
Oct 17, 2024Option exercise(M)9K$11.68$108K9K
Oct 17, 2024Sell(S)23$77.00$2K8K
Oct 17, 2024Sell(S)115$74.56$9K8K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 17, 2024Option exercise(M)953—$046K
Oct 17, 2024Option exercise(M)9K—$032K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-115723) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML